208 related articles for article (PubMed ID: 28299580)
61. A Decrease of Histone Deacetylase 6 Expression Caused by Helicobacter Pylori Infection is Associated with Oncogenic Transformation in Gastric Cancer.
He Q; Li G; Wang X; Wang S; Hu J; Yang L; He Y; Pan Y; Yu D; Wu Y
Cell Physiol Biochem; 2017; 42(4):1326-1335. PubMed ID: 28700998
[TBL] [Abstract][Full Text] [Related]
62. Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis.
Wang CY; Hua L; Yao KH; Chen JT; Zhang JJ; Hu JH
Int J Clin Exp Pathol; 2015; 8(1):779-85. PubMed ID: 25755774
[TBL] [Abstract][Full Text] [Related]
63. Increased Expression of DNAJC12 is Associated with Aggressive Phenotype of Gastric Cancer.
Uno Y; Kanda M; Miwa T; Umeda S; Tanaka H; Tanaka C; Kobayashi D; Suenaga M; Hattori N; Hayashi M; Yamada S; Nakayama G; Fujiwara M; Kodera Y
Ann Surg Oncol; 2019 Mar; 26(3):836-844. PubMed ID: 30617870
[TBL] [Abstract][Full Text] [Related]
64. Elevated FOXO6 expression correlates with progression and prognosis in gastric cancer.
Wang JH; Tang HS; Li XS; Zhang XL; Yang XZ; Zeng LS; Ruan Q; Huang YH; Liu GJ; Wang J; Cui SZ
Oncotarget; 2017 May; 8(19):31682-31691. PubMed ID: 28404958
[TBL] [Abstract][Full Text] [Related]
65. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
66. The expression of metastasis-associated in colon cancer-1 and KAI1 in gastric adenocarcinoma and their clinical significance.
Lu G; Zhou L; Zhang X; Zhu B; Wu S; Song W; Gong X; Wang D; Tao Y
World J Surg Oncol; 2016 Oct; 14(1):276. PubMed ID: 27793161
[TBL] [Abstract][Full Text] [Related]
67. ADAM 10 is associated with gastric cancer progression and prognosis of patients.
Wang YY; Ye ZY; Li L; Zhao ZS; Shao QS; Tao HQ
J Surg Oncol; 2011 Feb; 103(2):116-23. PubMed ID: 21259244
[TBL] [Abstract][Full Text] [Related]
68. High Expression of Peroxiredoxin 1 Is Associated with Epithelial-Mesenchymal Transition Marker and Poor Prognosis in Gastric Cancer.
Yu W; Wu J; Ning ZL; Liu QY; Quan RL
Med Sci Monit; 2018 Apr; 24():2259-2270. PubMed ID: 29656298
[TBL] [Abstract][Full Text] [Related]
69. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
[TBL] [Abstract][Full Text] [Related]
70. Loss of RUNX3 expression correlates with differentiation, nodal metastasis, and poor prognosis of gastric cancer.
Hsu PI; Hsieh HL; Lee J; Lin LF; Chen HC; Lu PJ; Hsiao M
Ann Surg Oncol; 2009 Jun; 16(6):1686-94. PubMed ID: 19290488
[TBL] [Abstract][Full Text] [Related]
71. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
[TBL] [Abstract][Full Text] [Related]
72. Coexpression of HMGA2 and Oct4 predicts an unfavorable prognosis in human gastric cancer.
Kong D; Su G; Zha L; Zhang H; Xiang J; Xu W; Tang Y; Wang Z
Med Oncol; 2014 Aug; 31(8):130. PubMed ID: 25037576
[TBL] [Abstract][Full Text] [Related]
73. CCL7 and CCL21 overexpression in gastric cancer is associated with lymph node metastasis and poor prognosis.
Hwang TL; Lee LY; Wang CC; Liang Y; Huang SF; Wu CM
World J Gastroenterol; 2012 Mar; 18(11):1249-56. PubMed ID: 22468089
[TBL] [Abstract][Full Text] [Related]
74. Sulfasalazine, a potent suppressor of gastric cancer proliferation and metastasis by inhibition of xCT: Conventional drug in new use.
Zhuang J; Liu X; Yang Y; Zhang Y; Guan G
J Cell Mol Med; 2021 Jun; 25(12):5372-5380. PubMed ID: 33988296
[TBL] [Abstract][Full Text] [Related]
75. Oct4 expression in gastric carcinoma: association with tumor proliferation, angiogenesis and survival.
El-Guindy DM; Wasfy RE; Abdel Ghafar MT; Ali DA; Elkady AM
J Egypt Natl Canc Inst; 2019 Nov; 31(1):3. PubMed ID: 32372156
[TBL] [Abstract][Full Text] [Related]
76. C14orf166 overexpression correlates with tumor progression and poor prognosis of breast cancer.
Cheang TY; Zhou HY; Chen W; Zhang B; Liu L; Yang J; Wang S; Li H
J Transl Med; 2016 Feb; 14():54. PubMed ID: 26883017
[TBL] [Abstract][Full Text] [Related]
77. [KDM6A mutation and expression in gastric cancer are associated with prognosis].
Li LL; Huang ZG; Wang YW; Lu M; Hu KW
Zhonghua Zhong Liu Za Zhi; 2020 Aug; 42(8):648-652. PubMed ID: 32867456
[No Abstract] [Full Text] [Related]
78. Claudin-6 is a single prognostic marker and functions as a tumor-promoting gene in a subgroup of intestinal type gastric cancer.
Kohmoto T; Masuda K; Shoda K; Takahashi R; Ujiro S; Tange S; Ichikawa D; Otsuji E; Imoto I
Gastric Cancer; 2020 May; 23(3):403-417. PubMed ID: 31654186
[TBL] [Abstract][Full Text] [Related]
79. Abnormal expression of paxillin correlates with tumor progression and poor survival in patients with gastric cancer.
Chen DL; Wang ZQ; Ren C; Zeng ZL; Wang DS; Luo HY; Wang F; Qiu MZ; Bai L; Zhang DS; Wang FH; Li YH; Xu RH
J Transl Med; 2013 Nov; 11():277. PubMed ID: 24180516
[TBL] [Abstract][Full Text] [Related]
80. Elevated Expression of NOTCH1 Associates with Lymph Node Metastasis of Gastric Cancer and Knock-Down of NOTCH1 Attenuates Tumor Cell Progression.
Huang B; Jin G; Qu C; Ma H; Ding C; Zhang Y; Liu W; Li W
Med Sci Monit; 2019 Dec; 25():9939-9948. PubMed ID: 31874951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]